Emcure Pharmaceuticals Limited (BOM:544210)
India flag India · Delayed Price · Currency is INR
1,384.80
-14.00 (-1.00%)
At close: Aug 8, 2025

Emcure Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
Net Income
-6,8134,9825,3206,6223,921
Upgrade
Depreciation & Amortization
-3,7433,0322,5122,3483,137
Upgrade
Other Amortization
-97.9892.5689.04100.2896.1
Upgrade
Loss (Gain) From Sale of Assets
--382.35-71.923.334.08-4.23
Upgrade
Asset Writedown & Restructuring Costs
-----436.95
Upgrade
Loss (Gain) From Sale of Investments
--58.04-25.32-1.21--
Upgrade
Stock-Based Compensation
-19.8939.6752.7657.1663.48
Upgrade
Other Operating Activities
-2,5262,4192,4151,4694,573
Upgrade
Change in Accounts Receivable
--1,434-1,506-3,398-1,729-3,301
Upgrade
Change in Inventory
--4,067-267.61663.85-3,072-3,413
Upgrade
Change in Accounts Payable
-1,7021,543-391.83,1572,315
Upgrade
Change in Other Net Operating Assets
--443.61736.2203.54-1,2761,053
Upgrade
Operating Cash Flow
-8,51710,9727,4697,6827,044
Upgrade
Operating Cash Flow Growth
--22.38%46.91%-2.78%9.05%40.80%
Upgrade
Capital Expenditures
--2,218-2,758-3,906-3,782-1,254
Upgrade
Sale of Property, Plant & Equipment
-306.01315.3712.7531.21125.14
Upgrade
Cash Acquisitions
---3,451--2,751-1,116
Upgrade
Sale (Purchase) of Intangibles
--1,852-313.6-127.67-187.87-202.65
Upgrade
Investment in Securities
-2,592-1,098-708.36-1,308-147.22
Upgrade
Other Investing Activities
-231.44179.46152.4109.4975.81
Upgrade
Investing Cash Flow
--940.01-7,125-4,577-7,888-2,518
Upgrade
Short-Term Debt Issued
--1,025976.791,759-
Upgrade
Long-Term Debt Issued
--5,4743,5763,7145,775
Upgrade
Total Debt Issued
--6,5004,5535,4735,775
Upgrade
Short-Term Debt Repaid
--5,225----981.67
Upgrade
Long-Term Debt Repaid
--9,420-5,310-3,777-4,814-4,548
Upgrade
Total Debt Repaid
--14,645-5,310-3,777-4,814-5,529
Upgrade
Net Debt Issued (Repaid)
--14,6451,190775.24659.17245.66
Upgrade
Issuance of Common Stock
-7,79276.6---
Upgrade
Common Dividends Paid
---542.55-361.71-542.55-180.85
Upgrade
Other Financing Activities
--1,287-2,366-1,868-1,635-1,954
Upgrade
Financing Cash Flow
--8,140-1,642-1,454-1,519-1,889
Upgrade
Foreign Exchange Rate Adjustments
--20.49-20.02-1.281.86-46.17
Upgrade
Miscellaneous Cash Flow Adjustments
----1002,141-
Upgrade
Net Cash Flow
--583.022,1851,336418.72,591
Upgrade
Free Cash Flow
-6,2998,2153,5633,9005,790
Upgrade
Free Cash Flow Growth
--23.32%130.58%-8.65%-32.65%50.40%
Upgrade
Free Cash Flow Margin
-7.98%12.34%5.95%6.66%11.50%
Upgrade
Free Cash Flow Per Share
-33.6845.4219.7021.5732.02
Upgrade
Cash Interest Paid
-1,2872,0821,7861,5531,845
Upgrade
Cash Income Tax Paid
-2,4692,2372,0053,1122,004
Upgrade
Levered Free Cash Flow
-2,7773,6701,6252,2975,053
Upgrade
Unlevered Free Cash Flow
-3,5914,9402,7813,2165,765
Upgrade
Change in Working Capital
--4,243505.17-2,922-2,919-3,346
Upgrade
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.